Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
A simple software method to increase the duty-cycle resolution in a digital pulse width modulation (DPWM)-controlled power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback